Miller AH - Search Results

1

Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha.

Pace TW, Hu F, Miller AH. Pace TW, et al. Among authors: miller ah. Brain Behav Immun. 2011 Nov;25(8):1716-24. doi: 10.1016/j.bbi.2011.07.227. Epub 2011 Jul 21. Brain Behav Immun. 2011. PMID: 21798341 Free PMC article.

2

Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine.

Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH. Pariante CM, et al. Among authors: miller ah. Mol Pharmacol. 1997 Oct;52(4):571-81. doi: 10.1124/mol.52.4.571. Mol Pharmacol. 1997. PMID: 9380019

3

Treatment of cytokine-induced depression.

Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ. Capuron L, et al. Among authors: miller ah. Brain Behav Immun. 2002 Oct;16(5):575-80. doi: 10.1016/s0889-1591(02)00007-7. Brain Behav Immun. 2002. PMID: 12401471 Review.

4

The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.

Miller AH, Vogt GJ, Pearce BD. Miller AH, et al. Neuropsychopharmacology. 2002 Dec;27(6):939-48. doi: 10.1016/S0893-133X(02)00381-0. Neuropsychopharmacology. 2002. PMID: 12464451

5

Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function.

Wang X, Wu H, Miller AH. Wang X, et al. Among authors: miller ah. Mol Psychiatry. 2004 Jan;9(1):65-75. doi: 10.1038/sj.mp.4001339. Mol Psychiatry. 2004. PMID: 14699442

6

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.

Capuron L, Ravaud A, Miller AH, Dantzer R. Capuron L, et al. Among authors: miller ah. Brain Behav Immun. 2004 May;18(3):205-13. doi: 10.1016/j.bbi.2003.11.004. Brain Behav Immun. 2004. PMID: 15050647 Clinical Trial.

7

Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells.

Wang X, Wu H, Lakdawala VS, Hu F, Hanson ND, Miller AH. Wang X, et al. Among authors: miller ah. Neuropsychopharmacology. 2005 Feb;30(2):242-9. doi: 10.1038/sj.npp.1300606. Neuropsychopharmacology. 2005. PMID: 15536494

8

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH. Raison CL, et al. Among authors: miller ah. Brain Behav Immun. 2005 Jan;19(1):23-7. doi: 10.1016/j.bbi.2004.05.001. Brain Behav Immun. 2005. PMID: 15581735

9

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.

Hu F, Wang X, Pace TW, Wu H, Miller AH. Hu F, et al. Among authors: miller ah. Mol Psychiatry. 2005 May;10(5):426-8. doi: 10.1038/sj.mp.4001644. Mol Psychiatry. 2005. PMID: 15700047 Free PMC article. No abstract available.

10

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.

Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM. Pace TW, et al. Among authors: miller ah. Am J Psychiatry. 2006 Sep;163(9):1630-3. doi: 10.1176/ajp.2006.163.9.1630. Am J Psychiatry. 2006. PMID: 16946190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters